Sustainability in drug discovery
| Autor: | Christophe Furman, Thomas Block, Michał J. Markuszewski, Eelko Hak, Bart De Spiegeleer, Gerrit J. Poelarends, Bartosz Wielgomas, Luke R. Odell, Per Larsson, Nicolas Willand, Serge Van Calenbergh, Evelien Wynendaele |
|---|---|
| Přispěvatelé: | PharmacoTherapy, -Epidemiology and -Economics, Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET), Chemical and Pharmaceutical Biology, Biopharmaceuticals, Discovery, Design and Delivery (BDDD) |
| Rok vydání: | 2021 |
| Předmět: |
Pharmacology
Drug discovery business.industry Pharmaceutical field World population Public relations Socio-economic dimension RS1-441 Pharmacy and materia medica Environmental Biotechnology Sustainability Ecological–environmental impact Drug development Other Clinical Medicine Drug Discovery Medicine and Health Sciences Annan klinisk medicin Pharmacology (medical) Miljöbioteknik Business |
| Zdroj: | Medicine in Drug Discovery, 12. Elsevier MEDICINE IN DRUG DISCOVERY Medicine in Drug Discovery, Vol 12, Iss, Pp 100107-(2021) |
| ISSN: | 2590-0986 |
| DOI: | 10.1016/j.medidd.2021.100107 |
| Popis: | Due to the expanding and ageing world population, the importance and use of medicines is expected to increase. However, this will lead to a greater impact on the ecosystem and our health in the long term. The concept of sustainability is rather slowly gaining traction and is currently still fragmented in the pharmaceutical field. A consortium of researchers from five European universities therefore advocates a global, systematic approach and places the emphasis on sustainability already in early stages of drug development, i.e. drug discovery. According to the researchers, the competent authorities, universities, research institutions and industrial organizations all need to take sustainability more into account. They summarized the most important opportunities on the basis of ten sustainability principles. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|